Feed VXRT
VX

Vaxart, Inc. VXRT OTC · Healthcare · United States

$0.36 -4.49% -$0.02

Market cap
$88.2M
Enterprise value
$60.3M
P/E
3.0x
Forward P/E
-
PEG
-
P/S
0.5x
P/FCF
2.8x
EV/EBITDA
1.6x
ROIC
38.3%
Gross margin
99.3%
Net margin
16.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-0.8x
Beta
1.06
Free float
98.3%

About the company

Vaxart, Inc. (VXRT) is an American biotechnology company specializing in vaccine research and development. The company focuses on an innovative adenovirus-based vaccine platform, which enables the creation of vaccines against various infectious diseases. Vaxart works on vaccines targeting viral infections, including influenza, respiratory viral diseases, and other infections. With its technological approach and research capabilities, Vaxart aims to bring new possibilities in the field of vaccination and treatment of infectious diseases. Vaxart, Inc. (VXRT) shares are an attractive choice for investors following the biotechnology sector and seeking investment opportunities in vaccines and viral disease treatments.

Sector

Healthcare

Industry

Biotechnology

CEO

Steven Lo

Employees

65

Headquarters

South San Francisco

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Revenue grew by 1,204% a year over the last 3 years.
  • What to watch: Earnings per share swing sharply from year to year.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 USD of revenue, 16 USD is left as net profit.
  • What speaks for it: It earns 38 USD a year on every 100 USD of invested capital.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: $35.1M against $7.22M.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy